메뉴 건너뛰기




Volumn 65, Issue 1, 2007, Pages 24-31

Modelling of increased homocysteine in ischaemic stroke: Post-hoc cross-sectional matched case-control analysis in young patients

Author keywords

Epidemiology; Homocysteine; Ischaemic stroke; Young patient

Indexed keywords

FIBRINOGEN; HOMOCYSTEINE; TRIACYLGLYCEROL;

EID: 34147179994     PISSN: 0004282X     EISSN: 16784227     Source Type: Journal    
DOI: 10.1590/S0004-282X2007000100007     Document Type: Article
Times cited : (6)

References (42)
  • 1
    • 0037164104 scopus 로고    scopus 로고
    • Homocysteine and risk of ischemic heart disease and stroke: A meta-analysis
    • Homocysteine Studies Collaboration
    • Homocysteine Studies Collaboration. Homocysteine and risk of ischemic heart disease and stroke: a meta-analysis. JAMA 2002;288: 2015-2022.
    • (2002) JAMA , vol.288 , pp. 2015-2022
  • 3
    • 34147174586 scopus 로고    scopus 로고
    • Total plasma homocysteine concentrations in 41 patients in the acute phase of ischaemic stroke
    • Atanassova PA, Angelova E, Semerdjieva M, Tzvetkova T. Total plasma homocysteine concentrations in 41 patients in the acute phase of ischaemic stroke. Bulg Neurol 2006;6:17-21.
    • (2006) Bulg Neurol , vol.6 , pp. 17-21
    • Atanassova, P.A.1    Angelova, E.2    Semerdjieva, M.3    Tzvetkova, T.4
  • 4
    • 0029066299 scopus 로고
    • Aquantitative assessment of plasma homocystein as a risk factor for vascular disease: Probable benefits of increasing folic acid intakes
    • Boushey CL, Beresford SA, Omenn GS, et al. Aquantitative assessment of plasma homocystein as a risk factor for vascular disease: probable benefits of increasing folic acid intakes. JAMA 1995;274:1049-1057.
    • (1995) JAMA , vol.274 , pp. 1049-1057
    • Boushey, C.L.1    Beresford, S.A.2    Omenn, G.S.3
  • 5
    • 0031723797 scopus 로고    scopus 로고
    • Total homocystein concentration and the likelihood of nonfatal stroke: Results from the Third National Health and Nutrition Examination Survey, 1988-1994
    • Giles WH, Croft JB, Greenlund KJ. Total homocystein concentration and the likelihood of nonfatal stroke: results from the Third National Health and Nutrition Examination Survey, 1988-1994. Stroke 1998;29: 2473-2477.
    • (1998) Stroke , vol.29 , pp. 2473-2477
    • Giles, W.H.1    Croft, J.B.2    Greenlund, K.J.3
  • 7
    • 17444387940 scopus 로고    scopus 로고
    • Association between plasmatic levels of homocysteine and stroke: A transversal analytic study
    • Harboe-Goncalves L, Vaz LS, Buzzi M. Association between plasmatic levels of homocysteine and stroke: a transversal analytic study. Arq Neuropsiquiatr 2005;63:97-103.
    • (2005) Arq Neuropsiquiatr , vol.63 , pp. 97-103
    • Harboe-Goncalves, L.1    Vaz, L.S.2    Buzzi, M.3
  • 8
    • 0344444764 scopus 로고    scopus 로고
    • Further evidence of interrelation between homocysteine and hypertension in stroke patients: A cross-sectional study
    • Mizrahi EH, Noy S, Sela BA, et al. Further evidence of interrelation between homocysteine and hypertension in stroke patients: a cross-sectional study. Isr Med Assoc J 2003;5:791-794.
    • (2003) Isr Med Assoc J , vol.5 , pp. 791-794
    • Mizrahi, E.H.1    Noy, S.2    Sela, B.A.3
  • 9
    • 4644320723 scopus 로고    scopus 로고
    • Clinical usefulness of plasma homocysteine in vascular disease
    • Hankey GJ, Eikelboom JW, Ho WK, et al. Clinical usefulness of plasma homocysteine in vascular disease. Med J Austr 2004;181:314-318.
    • (2004) Med J Austr , vol.181 , pp. 314-318
    • Hankey, G.J.1    Eikelboom, J.W.2    Ho, W.K.3
  • 10
    • 0032771346 scopus 로고    scopus 로고
    • Homocysteine metabolism
    • Selhub J. Homocysteine metabolism. Annu Rev Nutr 1999;19:217-246.
    • (1999) Annu Rev Nutr , vol.19 , pp. 217-246
    • Selhub, J.1
  • 11
    • 1842331509 scopus 로고    scopus 로고
    • Plasma homocystein as a risk factor for vascular disease. The European Concerted Action Project
    • Graham IM, Daly LE, Refsum HM. Plasma homocystein as a risk factor for vascular disease. The European Concerted Action Project. JAMA 1997;277:1775-1781.
    • (1997) JAMA , vol.277 , pp. 1775-1781
    • Graham, I.M.1    Daly, L.E.2    Refsum, H.M.3
  • 12
    • 0032499024 scopus 로고    scopus 로고
    • Homocystein? and atherotrombosis
    • Welch GN, Loscalzo J. Homocystein? and atherotrombosis. N Engl J Med 1998;338:1042-1050.
    • (1998) N Engl J Med , vol.338 , pp. 1042-1050
    • Welch, G.N.1    Loscalzo, J.2
  • 13
    • 12344309062 scopus 로고    scopus 로고
    • Homocystein and stroke: Evidence on a causal link from mendelian randomization
    • Casas JP, Bautista LE, Smeeth L, et al. Homocystein and stroke: evidence on a causal link from mendelian randomization. Lancet 2005; 365:224-231.
    • (2005) Lancet , vol.365 , pp. 224-231
    • Casas, J.P.1    Bautista, L.E.2    Smeeth, L.3
  • 14
    • 0037368292 scopus 로고    scopus 로고
    • Association between homocyst(e)ine levels and risk of vascular events
    • Kaplan ED. Association between homocyst(e)ine levels and risk of vascular events. Drugs Today (Barc) 2003;39:175-192.
    • (2003) Drugs Today (Barc) , vol.39 , pp. 175-192
    • Kaplan, E.D.1
  • 15
    • 0032501963 scopus 로고    scopus 로고
    • Low circulating folate and vitamin B6 concentrations: Risk factors for stroke, peripheral vascular disease, and coronary artery disease. European COMAC Group
    • Robinson K, Arheart K, Refsum H. Low circulating folate and vitamin B6 concentrations: risk factors for stroke, peripheral vascular disease, and coronary artery disease. European COMAC Group. Circulation 1998;97:437-443.
    • (1998) Circulation , vol.97 , pp. 437-443
    • Robinson, K.1    Arheart, K.2    Refsum, H.3
  • 16
    • 0028966321 scopus 로고
    • Association between plasma homocystein? concentrations and extracranial artery disease
    • Selhub J, Jacques PF, Bostom AG, et al. Association between plasma homocystein? concentrations and extracranial artery disease. N Engl J Med 1995;332:286-291.
    • (1995) N Engl J Med , vol.332 , pp. 286-291
    • Selhub, J.1    Jacques, P.F.2    Bostom, A.G.3
  • 17
    • 0025125821 scopus 로고
    • Aprospective study of acute cerebrovascular disease in the community: The Oxfordshire Community Stroke Project 1981-1986: incidence, case fatality rates and overall outcome at one year of cerebral infarction, primary intracerebral and subarachnoidal haemorrhage
    • Bamford J, Sandercock P, Dennis M, Burn J, Warlow CP. Aprospective study of acute cerebrovascular disease in the community: The Oxfordshire Community Stroke Project 1981-1986: incidence, case fatality rates and overall outcome at one year of cerebral infarction, primary intracerebral and subarachnoidal haemorrhage. J Neurol Neurosurg Psychiatry 1990;53:16-22.
    • (1990) J Neurol Neurosurg Psychiatry , vol.53 , pp. 16-22
    • Bamford, J.1    Sandercock, P.2    Dennis, M.3    Burn, J.4    Warlow, C.P.5
  • 18
    • 0346787876 scopus 로고    scopus 로고
    • Cerebral ischemia: New risk factors
    • Diaz J, Sempere AP. Cerebral ischemia: new risk factors. Cerebrovasc Dis 2004;17:43-50.
    • (2004) Cerebrovasc Dis , vol.17 , pp. 43-50
    • Diaz, J.1    Sempere, A.P.2
  • 19
  • 21
    • 18344364639 scopus 로고    scopus 로고
    • Plasma homocysteine concentration, C677T MTHFR genotype, and 844ins68bp CBS genotype in young adults with spontaneous cervical artery dissection and atherothrombotic stroke
    • Pezzini A, Del Zotto E, Arechetti S, et al. Plasma homocysteine concentration, C677T MTHFR genotype, and 844ins68bp CBS genotype in young adults with spontaneous cervical artery dissection and atherothrombotic stroke. Stroke 2002;33:664-669.
    • (2002) Stroke , vol.33 , pp. 664-669
    • Pezzini, A.1    Del Zotto, E.2    Arechetti, S.3
  • 22
    • 0036484629 scopus 로고    scopus 로고
    • Folic acid and homocysteine in age-related disease
    • Mattson MP, Kruman II, Duan W. Folic acid and homocysteine in age-related disease. Ageing Res Rev 2002;1:95-111.
    • (2002) Ageing Res Rev , vol.1 , pp. 95-111
    • Mattson, M.P.1    Kruman, I.I.2    Duan, W.3
  • 23
    • 0037406436 scopus 로고    scopus 로고
    • Homocysteine, renal function, and risk of cardiovascular disease
    • Clarke R, Lewington S, Landray M. Homocysteine, renal function, and risk of cardiovascular disease. Kidney Int 2003;84(Suppl):S131-S133.
    • (2003) Kidney Int , vol.84 , Issue.SUPPL.
    • Clarke, R.1    Lewington, S.2    Landray, M.3
  • 24
    • 19944406791 scopus 로고    scopus 로고
    • Relationship between plasma homocysteine concentration and urinary markers of tubulointerstitial injury
    • Ikegaya N, Yanagisawa C, Kumagai H. Relationship between plasma homocysteine concentration and urinary markers of tubulointerstitial injury. Kidney Int 2005;67:375-376.
    • (2005) Kidney Int , vol.67 , pp. 375-376
    • Ikegaya, N.1    Yanagisawa, C.2    Kumagai, H.3
  • 25
    • 18744368137 scopus 로고    scopus 로고
    • Homocysteine, renal disease and cardiovascular disease in a remote Australian Aboriginal community
    • McDonald S, Maguire G, Duarte N, et al. Homocysteine, renal disease and cardiovascular disease in a remote Australian Aboriginal community. Intern Med J 2005;35:289-294.
    • (2005) Intern Med J , vol.35 , pp. 289-294
    • McDonald, S.1    Maguire, G.2    Duarte, N.3
  • 26
    • 0035016253 scopus 로고    scopus 로고
    • Impaired homocysteine metabolism and atherothrombotic disease
    • Durand P, Prost M, Loreau N, et al. Impaired homocysteine metabolism and atherothrombotic disease. Lab Invest 2001;81:645-672.
    • (2001) Lab Invest , vol.81 , pp. 645-672
    • Durand, P.1    Prost, M.2    Loreau, N.3
  • 27
    • 0036890065 scopus 로고    scopus 로고
    • Homocysteine determinants and the evidence to what extent homocysteine determines the risk of coronary heart disease
    • De Bree A, Verschuren M, Kromhout D, et al. Homocysteine determinants and the evidence to what extent homocysteine determines the risk of coronary heart disease. Pharmacol Rev 2002;54:599-617.
    • (2002) Pharmacol Rev , vol.54 , pp. 599-617
    • De Bree, A.1    Verschuren, M.2    Kromhout, D.3
  • 28
    • 0038680324 scopus 로고    scopus 로고
    • Low vitamin B6 but not homocyst-(e)ine is associated with increased risk of stroke and transient ischemic attack in the era of folic acid grain fortification
    • Kelly PJ, Shih VE, Kistler JP, et al. Low vitamin B6 but not homocyst-(e)ine is associated with increased risk of stroke and transient ischemic attack in the era of folic acid grain fortification. Stroke 2003;34:51-54.
    • (2003) Stroke , vol.34 , pp. 51-54
    • Kelly, P.J.1    Shih, V.E.2    Kistler, J.P.3
  • 29
    • 0031648862 scopus 로고    scopus 로고
    • Serum homocysteine and risk of coronary heart disease and cerebrovascular disease in elderly men. A 10-year follow-up
    • Coen D, Stehouwer A, Matty P, et al. Serum homocysteine and risk of coronary heart disease and cerebrovascular disease in elderly men. A 10-year follow-up. Arterioscler Thromb Vasc Biol 1998;18:1895-1901.
    • (1998) Arterioscler Thromb Vasc Biol , vol.18 , pp. 1895-1901
    • Coen, D.1    Stehouwer, A.2    Matty, P.3
  • 30
    • 0037180524 scopus 로고    scopus 로고
    • Homocysteine testing in patients with acute ischemic stroke
    • Bushnell CD, Goldstein LB. Homocysteine testing in patients with acute ischemic stroke. Neurology 2002;26:1541-1546.
    • (2002) Neurology , vol.26 , pp. 1541-1546
    • Bushnell, C.D.1    Goldstein, L.B.2
  • 31
    • 0036144087 scopus 로고    scopus 로고
    • Hyperhomocysteinemia and other inherited prothrombotic conditions in young adults with a history of ischemic stroke
    • Madonna P, de Stefano V, Coppola A, et al. Hyperhomocysteinemia and other inherited prothrombotic conditions in young adults with a history of ischemic stroke. Stroke 2002;33:51-56.
    • (2002) Stroke , vol.33 , pp. 51-56
    • Madonna, P.1    de Stefano, V.2    Coppola, A.3
  • 33
    • 1542348438 scopus 로고    scopus 로고
    • Role of homocysteine in the acute phase of stroke
    • Ribo M, Montaner J, Monasterio J, et al. Role of homocysteine in the acute phase of stroke. Neurologia 2004;19:10-14.
    • (2004) Neurologia , vol.19 , pp. 10-14
    • Ribo, M.1    Montaner, J.2    Monasterio, J.3
  • 34
    • 1842844951 scopus 로고    scopus 로고
    • Mild hyperhomocysteinemia is a risk-factor in all etiological subtypes of stroke
    • Parnetti L, Caso V, Santucci A, et al. Mild hyperhomocysteinemia is a risk-factor in all etiological subtypes of stroke. Neurol Sci 2004;25: 13-17.
    • (2004) Neurol Sci , vol.25 , pp. 13-17
    • Parnetti, L.1    Caso, V.2    Santucci, A.3
  • 35
    • 0035152138 scopus 로고    scopus 로고
    • Plasma homocysteine concentrations in the acute and convalescent periods of atherothrombotic stroke
    • Meiklejohn DJ, Vickers MA, Dijkhuisen R, et al. Plasma homocysteine concentrations in the acute and convalescent periods of atherothrombotic stroke. Stroke 2001;32:57-62.
    • (2001) Stroke , vol.32 , pp. 57-62
    • Meiklejohn, D.J.1    Vickers, M.A.2    Dijkhuisen, R.3
  • 36
    • 0036161311 scopus 로고    scopus 로고
    • Changes in plasma homocyst(e)ine in the acute phase after stroke
    • Howard VG, Sides EG, Newman GC, et al. Changes in plasma homocyst(e)ine in the acute phase after stroke. Stroke 2002;33:473-474.
    • (2002) Stroke , vol.33 , pp. 473-474
    • Howard, V.G.1    Sides, E.G.2    Newman, G.C.3
  • 37
    • 0035698449 scopus 로고    scopus 로고
    • Homocysteine and atherothrombosis
    • Falk E, Zhou J, Moller J. Homocysteine and atherothrombosis. Lipids 2001;36:3-11.
    • (2001) Lipids , vol.36 , pp. 3-11
    • Falk, E.1    Zhou, J.2    Moller, J.3
  • 38
    • 0036218242 scopus 로고    scopus 로고
    • Risk factors for progression of aortic atheroma in stroke and transient ischemic attack patients
    • Sen S, Oppenheimer SM, Lima J, et al. Risk factors for progression of aortic atheroma in stroke and transient ischemic attack patients. Stroke 2002;33:930-935.
    • (2002) Stroke , vol.33 , pp. 930-935
    • Sen, S.1    Oppenheimer, S.M.2    Lima, J.3
  • 39
    • 84926426742 scopus 로고    scopus 로고
    • Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: An individual participant meta-analysis
    • Fibrinogen Studies Collaboration
    • Fibrinogen Studies Collaboration. Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis. JAMA 2005;294:1799-1809.
    • (2005) JAMA , vol.294 , pp. 1799-1809
  • 40
  • 41
    • 9144225352 scopus 로고    scopus 로고
    • Facts and recommendations about total homocysteine determinations: An expert opinion
    • Refsum H, Smith AD, Ueland PM, et al. Facts and recommendations about total homocysteine determinations: an expert opinion. Clin Chem 2004;50:3-33.
    • (2004) Clin Chem , vol.50 , pp. 3-33
    • Refsum, H.1    Smith, A.D.2    Ueland, P.M.3
  • 42
    • 33645777279 scopus 로고    scopus 로고
    • Homocysteine trials - clear outcomes for complex reasons
    • Loscalzo J. Homocysteine trials - clear outcomes for complex reasons. N Engl J Med 2006;354:1629-1632.
    • (2006) N Engl J Med , vol.354 , pp. 1629-1632
    • Loscalzo, J.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.